Tuesday, 02 January 2024 12:17 GMT

Loomis Expands Its Pharma Business By Acquiring Kipfer-Logistik


(MENAFN- PR Newswire)

STOCKHOLM, Sweden, July 24, 2025 /PRNewswire/ -- Loomis AB has, through its subsidiary Loomis International Corporate AG, entered into an agreement to acquire 100 percent of Kipfer-Logistik GmbH.

Kipfer-Logistik is a logistics company based in Switzerland, which specializes in temperature-controlled transport and storage in the pharmaceutical and healthcare sectors. The company had revenues of approximately CHF 9 million (SEK 108 million) in 2024 and has 28 employees.

Loomis has been offering the transportation of pharmaceutical products in temperature-controlled environments on a smaller scale in Switzerland since 2024 under the brand of Loomis Pharma. The acquired business will be reported in the International business line within Segment Europe and Latin America and consolidated into Loomis as of closing of the transaction. The acquisition is expected to be completed on September 1, 2025, subject to certain conditions.

"This acquisition accelerates the growth of Loomis Pharma by integrating a well-established Swiss logistics company specializing in high-security and temperature-controlled road freight transport. Together, we will provide our customers with an even more comprehensive range of services, thereby strengthening our market position," says Aritz Larrea, President and CEO of Loomis.

The acquisition is expected to be accretive to the Group's operating profit (EBITA1) and the earnings per share for 2025.

1) Earnings Before Interest, Taxes, Amortization of acquisition-related intangible fixed assets, Acquisition-related costs and revenue and items affecting comparability.

This press release is also available on the company's website, .

For more information, please contact:

Jenny Boström
Head of Sustainability and IR
[email protected]
+46 79 006 45 92

This information was brought to you by Cision

,c4210954

The following files are available for download:

Loomis expands its Pharma business by acquiring Kaspar

SOURCE Loomis AB

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN24072025003732001241ID1109843222



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.